Real-time Stock quotes, portfolio, LIVE TV and more.
Oct 10, 2011, 07.14 PM IST
ICRA has come out with its report on Indoco Remedies. The research firm has assigned the fundamental Grade ‘3+’ and the valuation grade ‘A’ to the company, in its October 05, 2011 report.
ICRA has come out with its report on Indoco Remedies . The research firm has assigned the fundamental Grade ‘3+’ and the valuation grade ‘A’ to the company, in its October 05, 2011 report.
ICRA Online has assigned the Fundamental Grade ‘3+’ and the Valuation Grade ‘A’ to Indoco Remedies Limited (Indoco). The Fundamental Grade ‘3+’ assigned to Indoco implies that the company has “good fundamentals” relative to other listed securities in India. The Valuation Grade ‘A’ assigned to Indoco implies that the company is “significantly undervalued’ on a relative basis (as on the date of the grading assigned).
Incorporated in 1947, Indoco Remedies is engaged in the manufacturing and marketing of Formulations and APIs for domestic branded generics market contributing 67% of the revenues. The company also has an international presence through its fast growing formulation and API export business to regulated as well as semi-regulated markets.
Valuation Grading: In assessing a company's valuation, various parameters are looked at including the company's earnings and growth prospects, its ability to generate free cash flows, and its capacity to generate returns from the capital invested. The valuation is also benchmarked against an appropriate peer set or index. The opinion on a company's relative valuation is expressed using the following five-point scale as follows:
ICRA Equity Research Service - Valuation Grades
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
To read the full report click here
May 21 2013, 13:56
- in Results Boardroom
May 21 2013, 11:05
- in MARKET OUTLOOK